Buyback of Class B shares in Essity during week 5, 2026

Between January 26, 2026, and January 30, 2026, Essity Aktiebolag (publ) repurchased a total of 170,916 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.

The share purchase is part of the SEK 3bn buyback program announced by Essity on April 23, 2025. The buyback program will extend from April 24, 2025, until the 2026 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission’s Delegated Regulation 2016/1052 (Safe Harbour Regulation).

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity’s capital allocation.

Class B shares in Essity were repurchased as follows:

Date
Aggregated daily volume (no. of shares):
Weighted average price per day (SEK):
Total daily transaction value (SEK):
January 26, 2026
26,850
256.1759
6,878,323
January 27, 2026
14,891
256.7309
3,822,980
January 28, 2026
101,592
255.3614
25,942,675
January 29, 2026
13,808
258.9440
3,575,499
January 30, 2026
13,775
261.7161
3,605,139
Total accumulated during week 5 2026
170,916
256.4103
43,824,616
Total accumulated during the buyback program
10,257,281
258.2167
2,648,600,834

All purchases were conducted on Nasdaq Stockholm by BofA Securities Europe SA on behalf of Essity. Following the above purchases, Essity’s holding of treasury shares amounted on January 30, 2026, to 11,039,781 Class B shares. The total number of shares in Essity amounted on the date of this press release to 693,054,489, of which 57,200,658 Class A shares and 635,853,831 Class B shares.                

For additional information, please contact:
Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2025, Essity had net sales of approximately SEK 138bn (EUR 13bn) and employed 36,000 people. The company’s headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.

Läs mer på Cision

Ämnen i artikeln


Essity B

Senast

265,40

1 dag %

0,84%

1 dag

1 mån

1 år

Essity A

Senast

265,00

1 dag %

0,95%
Marknadsöversikt

1 DAG %

Senast

1 mån